Bloomberg's Berens on Health-Care Law, Drug Costs

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Sept. 10 (Bloomberg) -- Andrew Berens, pharmaceuticals analyst for Bloomberg Industries, talks about the outlook for drug costs and U.S. health-care law. Berens speaks with Tom Keene and Sara Eisen on Bloomberg Television's "Surveillance." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change